吳 佳璋

Medicine & Life Sciences

1. Nephroureterectomy 100%
2. Carcinoma 95%
3. Arsenic 62%
4. Urinary Bladder 48%
5. Testosterone 47%
6. Urinary Bladder Neoplasms 46%
7. Uropathogenic Escherichia coli 42%
8. Survival 41%
9. Prostatic Neoplasms 36%
10. Cohort Studies 33%
11. Recurrence 33%
12. Neoplasms 32%
13. Meta-Analysis 29%
14. Herniorrhaphy 28%
15. Inguinal Hernia 28%
16. Urinary Tract 27%
17. Genotype 25%
18. Interleukin-8 22%
19. Renal Cell Carcinoma 22%
20. Methylation 21%
21. Odds Ratio 20%
22. Percutaneous Nephrolithotomy 20%
23. Disease-Free Survival 19%
24. Castration 19%
25. Hand 19%
26. Confidence Intervals 18%
27. Escherichia coli Infections 17%
28. Erectile Dysfunction 17%
29. Population 17%
30. Extracorporeal Shockwave Therapy 16%
31. human LTB protein 16%
32. Robotics 15%
33. human MIRN590 microRNA 15%
34. Genes 15%
35. Adjuvant Chemotherapy 15%
36. Prostatitis 14%
37. Tumor Necrosis Factor-alpha 14%
38. Prostate 14%
39. Nocturnal Enuresis 14%
40. Cigarette Smoking 14%
41. Lymphotoxin beta Receptor 12%
42. MDV 3100 12%
43. Urologic Neoplasms 12%
44. Young Adult 12%
45. Hernia 12%
46. Cardiovascular Diseases 11%
47. Databases 11%
48. Phimosis 11%
49. Foot Diseases 11%